Ixazomib in combination to thalidomide - dexamethasone for patients with relapsed and/or refractory multiple myeloma
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2017
At a glance
- Drugs Ixazomib (Primary) ; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 25 Jun 2017 Interim results (n=67) assessing activity and tolerability of ixazomib plus thalidomide and dexamethasone, presented at the 22nd Congress of the European Haematology Association.
- 06 Dec 2016 Interim analysis (n=39) was presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 28 Jan 2015 New trial record